Neurocrine Biosciences Inc

NBIXNASDAQ • USD
167.50 USD
↗ 0.10 (0.06%)🟢PRE MARKET (AS OF 08:50 AM EST)
🟢Market: OPEN

NBIX is currently priced at $167.50. Our models show a "Strong Buy" technical signal alongside a "Neutral" fundamental rating. This is driven by a robust Altman Z-Score, a weak Piotroski F-Score of 2/9 and a bullish Golden Cross on the moving averages. On valuation, NBIX trades roughly in line with sector averages — neither particularly cheap nor expensive.

Technical & fundamental data as of Nov 13, 2026.

Open?$163.34
High?$169.94
Low?$163.34
Prev. Close?$167.40
Volume?29
Avg. Volume?1.4M
VWAP?$166.54
Rel. Volume?0.00x
Bid / Ask
Bid?$158.85 × 100
Ask?$176.15 × 100
Spread?$17.30
Midpoint?$167.50
Valuation & Ratios
Market Cap?16.9B
Shares Out?101.2M
Float?97.4M
Float %?95.8%
P/E Ratio?24.12
P/B Ratio?4.37
EPS?$6.94
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Neurocrine Biosciences Inc is a biopharmaceutical firm focused on the research, development, and commercialization of treatments for neurological, psychiatric, endocrine, and immunological disorders. Its portfolio includes therapies for conditions such as tardive dyskinesia, chorea associated with Huntington's disease, classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency, and treatments for endometriosis and uterine fibroids. The company also maintains a pipeline of drug candidates in various stages of clinical and preclinical development across its therapeutic areas, including small molecules, peptides, proteins, antibodies, conjugates, and gene therapies. It derives revenue from the sale of its pharmaceutical products.
Employees
2.5K
Market Cap
16.9B
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Listed
1996-05-23
Address
6027 EDGEWOOD BEND COURT
SAN DIEGO, CA 92130
Phone: (858) 617-7600
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+3/3)
Medium-Term (Wave)?▲ Bullish(+2/3)
Short-Term (Ripple)?▼ Bearish(-2/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?
12
Z-Score?
100
Momentum?
60
Short Sent.?
74
Piotroski F-Score?2/9Weak
Altman Z-Score?7.40Safe
Confidence?58%Low
Full Fundamental Analysis →
Short InterestHigh
Short % of Float?6.06%Elevated
Short Interest?5.9M
Days to Cover?5.4
Free Float97.4M
Avg Daily Volume1.1M
Settlement Date2026-10-30
Financial Health
Current Ratio?2.04Strong
Quick Ratio?1.97Adequate
Cash Ratio?0.65Adequate
Debt/Equity?0.00Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score
72/100
P/E?
Peers
100
S&P
50
24.1FAIR▾
P/B?
Peers
100
S&P
41
4.37FAIR▾
P/S?
Peers
100
S&P
33
4.58FAIR▾
P/FCF?
Peers
100
S&P
69
16.3CHEAP▾
EV/EBITDA?
Peers
100
S&P
41
16.4FAIR▾
EV/Sales?
Peers
100
S&P
42
4.40FAIR▾
Returns & Efficiency
ROE?
Peers
50
S&P
62
18.1%STRONG▾
ROA?
Peers
50
S&P
82
12.5%STRONG▾
Cash Flow & Enterprise
FCF?$1.0B
Enterprise Value?$16.3B
Fundamentals ratios updated end of day